- Home
- SVT vs LGVN Comparison
SVT vs LGVN Comparison
Compare SVT & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVT
- LGVN
- Stock Information
- Founded
- SVT 1959
- LGVN 2014
- Country
- SVT United States
- LGVN United States
- Employees
- SVT N/A
- LGVN N/A
- Industry
- SVT Industrial Machinery/Components
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- SVT Consumer Discretionary
- LGVN Health Care
- Exchange
- SVT Nasdaq
- LGVN Nasdaq
- Market Cap
- SVT 27.1M
- LGVN 27.6M
- IPO Year
- SVT N/A
- LGVN 2021
- Fundamental
- Price
- SVT $10.60
- LGVN $1.50
- Analyst Decision
- SVT
- LGVN Strong Buy
- Analyst Count
- SVT 0
- LGVN 3
- Target Price
- SVT N/A
- LGVN $8.67
- AVG Volume (30 Days)
- SVT 921.0
- LGVN 201.4K
- Earning Date
- SVT 05-09-2025
- LGVN 05-13-2025
- Dividend Yield
- SVT N/A
- LGVN N/A
- EPS Growth
- SVT N/A
- LGVN N/A
- EPS
- SVT N/A
- LGVN N/A
- Revenue
- SVT $44,917,000.00
- LGVN $2,392,000.00
- Revenue This Year
- SVT N/A
- LGVN $26.05
- Revenue Next Year
- SVT N/A
- LGVN $12.27
- P/E Ratio
- SVT N/A
- LGVN N/A
- Revenue Growth
- SVT 2.95
- LGVN 237.38
- 52 Week Low
- SVT $10.16
- LGVN $0.77
- 52 Week High
- SVT $13.75
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- SVT 48.06
- LGVN 48.73
- Support Level
- SVT $10.33
- LGVN $1.44
- Resistance Level
- SVT $10.70
- LGVN $1.92
- Average True Range (ATR)
- SVT 0.23
- LGVN 0.12
- MACD
- SVT -0.03
- LGVN -0.01
- Stochastic Oscillator
- SVT 32.08
- LGVN 37.71
About SVT Servotronics Inc.
Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.